Clinical Trial Update: A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating the combination of Botensilimab and Balstilimab for colorectal cancer with detectable ctDNA after surgery and chemot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Balstilimab (balstilimab)
• Botensilimab (botensilimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Colorectal Cancer, Rectal Cancer | Phase 2 | Status: RECRUITING